In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV, and HCV), performed on the Tigris testing platform, to the newer Ultrio Elite triplex assay, and performed on the Panther testing platform. The CTS Phoenix lab will implement first on July 7th, with the 4 remaining CTS labs located in Charlotte, Dallas, St. Louis amd Tampa all implementing on July 13, 2020.
Click here for all the details: Communications
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
This is the first update to the original CTS communication distributed on July 6th. As previously co...
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
Reminder - On Wednesday June 6, 2018 at 10:00AM PST, we will be hosting a webinar regarding the chan...
Reminder - Five CTS Forms will be updated on Monday September 2, 2019. Some of the forms are posted ...